Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.
The Biden administration's eleventh hour move to expand Medicare coverage for anti-obesity drugs is likely to be popular ...
Shares in Amgen fell by double digits Tuesday on results for the company’s MariTide shot, which is viewed as a potential ...
A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.
A new rule proposed by CMS presents alterations to the Medicare program, including expanded coverage for anti-obesity ...
The Biden administration is proposing a new rule that would make popular weight loss drugs like Ozempic covered by Medicare ...
1don MSN
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...
Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback